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A B S T R A C T   
Background: Integrating epilepsy care into primary care settings could reduce the global burden of illness 
attributable to epilepsy. Since 2012, the Rwandan Ministry of Health and the international nonprofit Partners In 
Health have collaboratively used a multi-faceted implementation program- MESH MH—to integrate and scale-up 
care for epilepsy and mental disorders within rural primary care settings in Burera district, Rwanda. We here 
describe demographics, service use and treatment patterns for patients with epilepsy seeking care at MESH-MH 
supported primary care health centers. 
Methods and findings: This was a retrospective cohort study using routinely collected data from fifteen health 
centers in Burera district, from January 2015 to December 2016. 286 patients with epilepsy completed 3307 
visits at MESH-MH participating health centers over a two year period (Jan 1st 2015 to Dec 31st 2016). Men 
were over twice as likely to be diagnosed with epilepsy than women (OR 2.38, CI [1.77–3.19]), and children 
under 10 were thirteen times as likely to be diagnosed with epilepsy as those 10 and older (OR 13.27, CI 
[7.18–24.51]). Carbamazepine monotherapy was prescribed most frequently (34% of patients). 
Conclusion: Task-sharing of epilepsy care to primary care via implementation programs such as MESH-MH has the 
potential to reduce the global burden of illness attributable to epilepsy.   
1. Introduction 
Epilepsy is a common, chronic neurological disorder that dispro-
portionately affects people living in low and lower-middle income 
countries, particularly sub-Saharan Africa [1,2]. Epilepsy accounts for 
over ten million disability adjusted life years (DALYs) globally, and se-
vere epilepsy is among the 10% of disorders with the highest estimated 
disability weights, alongside AIDS and metastatic terminal cancer [3]. 
Treatment for epilepsy is highly effective, yet it is estimated that more 
than three quarters of people living with epilepsy in low-resource set-
tings do not receive treatment [4]. Significant barriers to effective 
treatment continue to exist, including a paucity of health workers 
trained and supervised in the diagnosis and treatment of epilepsy, 
challenges in antiepileptic medication supply chain management, 
limited access to diagnostic tools and equipment, and health systems 
which are poorly conducive to the integration of chronic care. Increas-
ingly, task sharing or task shifting—the redistribution of responsibilities 
from higher trained health workers to less highly trained health workers 
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in order to maximize efficiency of health workforce resources—is being 
adapted for the care of epilepsy in low-resource settings and in sub- 
Saharan Africa [5,6]. With regard to culture, due to stigma and fear 
embedded within communities and health systems, health care pro-
viders are still often reluctant to interact with or touch people living 
with epilepsy, due to fears of spiritual malaise or demonic possession 
[7]. From a policy perspective, the variable placement of epilepsy within 
non-communicable disease and mental health policies and frameworks 
in many countries may create the additional risk of further under- 
prioritization and inadequate resource allocation for epilepsy preven-
tion and care. Despite these challenges, epilepsy remains a highly 
treatable condition. 
Rwanda’s current National Strategic Plan for Mental Health aims to 
address the country’s burden of neuropsychiatric disorders by placing 
mental health and neurologic services, including epilepsy, within public 
district health systems, and decentralizing care from the national 
neuropsychiatric referral hospital into district continuums of care [8]. 
There is now at least one psychiatric nurse with training in epilepsy 
diagnosis and management at each district general hospital in the 
country [9], yet the treatment gap for epilepsy is estimated to remain at 
68% across rural areas of the country [10]. The National Plan also ad-
vocates for the integration of mental and neurologic care into primary 
care settings, in order to expand evidence-based treatment for epilepsy 
to underserved areas of the country, and address ongoing limitations in 
the number of available specialized providers for neurologic and psy-
chiatric disorders. 
Partners In Health (PIH), an international non-governmental orga-
nization known locally as Inshuti Mu Buzima (IMB), has been working to 
support the health system strengthening in three rural districts in 
Rwanda since 2005, with mental health systems strengthening formally 
initiated in 2009. Beginning in 2012, IMB/PIH and the MoH collabo-
ratively adopted a set of implementation strategies to integrate neuro-
psychiatric care into primary care, called the MESH-MH (Mentoring and 
Enhanced Supervision at Health Centers for Mental Health) imple-
mentation program. The program is based on an existing set of strategies 
designed to improve care quality in a variety of clinical domains in IMB- 
supported districts of Rwanda, including care for chronic non- 
communicable diseases [11]. MESH- MH has been described in detail 
elsewhere [9,12,13]. Between 2012 and 2016 services for severe mental 
disorders and epilepsy were scaled to 19 health centers across the rural 
district of Burera, Rwanda, supported by the MESH- MH implementation 
program. 
There exists a paucity of literature describing service use patterns for 
people with epilepsy receiving care within health systems focused on 
decentralizing mental health and neurologic care to primary care set-
tings. We have previously examined mental health service use trends as 
services were moved from district specialized mental health clinics into 
primary care health centers [14]. People with epilepsy may have service 
needs which differ from other users of mental health services [15]. The 
aim of this work was to describe demographics, service use, and treat-
ment patterns for patients with epilepsy receiving care from non- 
specialists in health centers in one rural district of Rwanda. 
2. Methods 
2.1. Study design 
A descriptive retrospective cohort design was used and routinely 
collected data from all patients who received mental health care at 
health centers in Burera district supported by the MESH MH model were 
collated. 
2.2. Study setting 
The study was conducted in rural Burera District, Northern Province, 
Rwanda. Burera is a rural district with a population of about 340,000, 
and is served by 19 primary care health centers throughout the district. 
The primary referral center for the health centers is the 150-bed public 
Butaro District Hospital. Approximately 1500 community health 
workers link rural communities to the health system via health center 
referrals, and engage in case finding, psychoeducation, treatment 
adherence and follow up support. Mental health and neurologic service 
provision in the district is provided at the district specialized mental 
health clinic, and at the primary care centers by non-specialist primary 
care nurses. Through the MESH-MH program, primary care nurses are 
equipped to perform patient assessments, provide treatment including 
basic medication management and psychoeducation, coordinate com-
munity support, and manage follow-up care. The program has focused 
primarily on four mental and neurologic disorders: epilepsy; schizo-
phrenia; bipolar disorder; and severe depression. Complicated cases or 
patients requiring acute care are referred to the local government ter-
tiary care center in the district, Butaro District Hospital. All clinical 
providers are employed by the government within Ministry of Health 
facilities. Mental health care delivery in the district is further supported 
by the IMB mental health team, which, at the time of the study, included 
one program manager, one community coordinator, one research 
coordinator, and several data officers, along with an expatriate psychi-
atrist, the Pagenel Fellow in Global Mental Health Delivery (http://gh 
sm.hms.harvard.edu/education/fellowships#pagenel). Together the 
IMB mental health team and the Pagenel Fellow are supported by a PIH 
cross-site mental health team, which includes several psychiatrists with 
extensive experience in mental health care delivery and system 
development. 
2.3. Study population 
All patients diagnosed with epilepsy who attended at least one visit 
to a health center supported by the MESH MH program between January 
1st, 2015 and January 31st, 2016 were included in the analysis. The 
diagnosis of epilepsy was established by clinical history (at least two 
recurrent unprovoked seizures) and exam. The follow up period 
included visits occurring between January 2nd, 2015 and December 
31st, 2016. Patients attending MESH MH supported health centers who 
were diagnosed with a mental disorder were also included as a com-
parison group in the analysis. 
2.4. Data collection 
Patient data were recorded by primary care nurses on mental health 
specific paper registers at each participating health center. The IMB 
supported data officers abstracted disaggregated patient variables from 
the paper registers into a centralized Microsoft Access Database 
(Microsoft Corp, Redmond, Washington, USA). Collected variables 
included: gender, age, health center name, patient residence (home 
village), primary and secondary diagnosis, antiepileptic treatment reg-
imens, and the dates of individual patients’ appointments. 
2.5. Data analysis 
Diagnoses recorded by the assessing clinician at the patient’s first 
visit were used for analysis. Mental disorders other than epilepsy were 
combined into one category, labeled “non-epilepsy diagnoses”. Age was 
divided into three categories comprised of young children (<10 years), 
older children and adolescents (10–19 years) and adults (>19 years). 
Distance from home to health facility was dichotomized into </= 5 km 
or > 5 km. Service use was assessed by calculating the total number of 
visits for mental health and epilepsy care, at health centers during the 
two year study period. The number of patients with a second visit to any 
health center for care within 90 days of their first visit was calculated. 
The number of patients with at least five visits, each within 90 days of 
the previous visit, was also calculated. Individuals with missing data on 
a given factor were excluded from analyses of that variable. Numbers 
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and percentages are reported for categorical variables; all reports 
regarding pairwise variable associations used a two-tailed Fisher’s exact 
test with a 5% significance level. For age group, we computed a p-value 
for the association between each group and epilepsy diagnosis by 
aggregating all other groups and analyzing the resulting 2 × 2 table with 
Fisher’s exact test. A multiple logistic regression analysis was used to 
determine whether, among patients with an epilepsy diagnosis, patient 
gender, age, distance from home to the health facility, and presence of 
co-morbidity, were significant predictors of follow up for a second and 
fifth visit. Data were analyzed using Stata v.15.1 (Stata Corp, College 
Station, Texas). 
2.6. Ethics approval 
This study, titled “Delivery of Non-Communicable Chronic Disease 
Care at PIH-supported Districts in Rwanda: Clinical and Programmatic 
Outcomes” received ethics approval from the Rwanda National Ethical 
Committee (RNEC). 
3. Results 
There were 286 unique patients with epilepsy seen at the fifteen 
health centers in Burera District participating in the MESH MH 
implementation program between January 1st 2015 and January 31st 
2016. Patient characteristics are described in Table 1. 
People with epilepsy represented 36% of the total number of patients 
receiving mental or neurologic care at MESH MH participating health 
centers during the same period. Men receiving services were over twice 
as likely to be diagnosed with epilepsy as women (OR 2.38, CI 
[1.77–3.19]). Epilepsy was the predominant diagnosis among children; 
children under 10 were thirteen times as likely to be diagnosed with 
epilepsy as individuals 10 and over (OR 13.27, CI [7.18–24.51]). Most 
(88%) patients attending services with epilepsy lived within a short 
walking distance (< 5 km) to a health center. There were no significant 
differences in the distance traveled to the health centers between those 
with epilepsy and those without epilepsy. Tegretol (carbamazepine) 
monotherapy was prescribed most frequently (34% of patients), fol-
lowed by Depakote/Depakene (valproic acid) (27%) and phenobarbital 
(24%) (Table 2). 
286 patients with epilepsy completed a total of 3307 visits for epi-
lepsy care during the period from January 1st 2015 to Dec 31st 2016. Of 
these 286, 233 (81.5%) returned within 90 days for a second visit and 
167 (58.3%) of total patients returned for at least five total visits, each 
within 90 days of the first. Patients with epilepsy were more likely to 
return for both a second and a fifth visit than patients with other di-
agnoses of a mental disorder (p < 0.01) (Table 3). 
The effect of gender, age, distance from home to health center, or 
comorbidity on fifth visit attendance did not reach statistical signifi-
cance in logistic regression analysis for patients with epilepsy (Table 4), 
although when all patients were analyzed the effect of distance on fifth 
visit attendance was highly significant (p < 0.01). 
4. Discussion 
Our study is one of the first to characterize demographics, service use 
and follow-up, and treatment patterns for patients with epilepsy 
receiving care in primary care settings in rural sub-Saharan Africa. Our 
findings reinforce the feasibility of task-sharing to deliver epilepsy care 
to populations without access to specialized services. According to the 
World Health Organization (WHO), one hundred million people 
worldwide will be diagnosed with epilepsy at some point in their lives, 
the majority of whom live in resource-limited settings, yet basic phar-
macological and psychosocial care for epilepsy for the majority of these 
individuals has not been achieved [16]. The innovative PIH/MoH 
collaborative implementation program MESH MH addresses this treat-
ment gap by using a set of basic implementation strategies to facilitate 
front-line public primary care nurses to provide basic care for patients 
with epilepsy and mental disorders. 
In our study, patients with epilepsy were more likely to be children, 
and 85% of children under 10 who were seen at the MESH MH supported 
services were diagnosed with epilepsy. Globally, the burden of epilepsy 
is high among children [17]. In sub-Saharan Africa, it is estimated that 
over 90% of people with epilepsy are younger than 20 years old [1], and 
the prevalence of epilepsy in children is estimated to be between 3.6 and 
44/1000, with higher rates in rural areas [17]. The most common risk 
factors for epilepsy in resource-limited countries has been attributed to 
birth-related trauma, traumatic brain injuries, and central nervous sys-
tem (CNS) infections, as well as inadequate access to quality health 
Table 1 
Characteristics of people with and without epilepsy receiving neurologic and 
mental health care at MESH-MH supported health centers in Burera District, 
Rwanda, January 2015 to January 2016.   
Persons with epilepsy 
diagnosis n (%) 
Non-epilepsy 
diagnosis n (%) 
Gender (n = 814)   
Male 163 (57.0) 189 (35.8) 
Female 123 (43.0) 339 (64.2) 
Age group (n = 754)   
<10 years 72 (26.8) 13 (2.7) 
10–19 years 68 (25.3) 54 (11.1) 
≥20 years 129 (48.0) 418 (86.2) 
Distance from home to the health 
facility (n = 764)   
<5 km 235 (88.3) 448 (90.0) 
≥5 km 31 (11.7) 50 (10.0) 
Comorbidity (n = 286)   
None 256 (90%) – 
Depression 3 (1%) – 
Psychosis 7 (2%) – 
Other 20 (7%) –  
Table 2 
Treatment regimens (n = 283)a  
Anti-epileptic medication N (%) 
Carbamazepine/Tegretol 97 (34.2) 
Phenobarbital 70 (24.7) 
Depakine/Depakote 71 (25.1) 
Other 7 (2.5) 
Polytherapy 38 (13.4)  
a Medication data were missing for three patients. 
Table 3 
Patient follow up visit attendance by diagnosis.  
Visit Epilepsy diagnosis Non-epilepsy diagnosis Total P-value 
n % returning (n/N) n % returning (n/N) n % returning (n/N) 
Initial visit 286 – 529 – 815 – – 
Second visit* 233 81.5% (233/286) 375 70.9% (375/529) 608 74.6% (608/815) <0.01 
Fifth visit** 167 58.3% (167/286) 241 45.5% (241/529) 408 50.1% (408/815) <0.01  
* Second visit defined as occurring within 90 days of first visit 
** Each visit from second to fifth occurred within 90 days of the previous visit 




Predictors of attendance at a second and fifth visit for people with epilepsy*,**   



























Gender (n = 286)             
Male 130 (55.8) 33 (62.3)     94 (56.3) 69 (58.0)     
Female 103 (44.2) 20 (37.7) 1.31 [0.68–2.55] 0.44 1.66 [0.79–3.45] 0.18 73 (43.7) 50 (42.0) 1.07 [0.65–1.77] 0.81 1.18 
[0.69–2.00] 
0.55 
Age group (n = 269)             
<10 years 61 (27.6) 11 (22.9) 1.28 [0.59–2.97] 0.59 1.39 [0.61–3.15] 0.18 47 (29.7) 25 (22.5) 1.45 [0.80–2.67] 0.21 1.35 
[0.74–2.47] 
0.32 
10–19 years 54 (24.4) 14 (29.2) 0.79 [0.38–1.71] 0.58 0.92 [0.41–2.05] 0.83 41 (26.0) 27 (24.3) 1.09 [0.60–2.00] 0.78 1.36 
[0.73–2.53] 
0.033 
≥20 years 106 (48.0) 23 (47.9) 1.00 [0.51–1.97] 1.00 0.83 [0.22–1.91] 0.43 70 (44.3) 59 (53.2) 00.70 [0.42–1.18] 0.17 0.63 
[0.37–1.06] 
0.08 
Distance from home to 
health facility (n =
266)*             
<5 km 197 (89.1) 38 (84.4)     146 (91.2) 89 (84.0)     
≥5 km 24 (10.9) 7 (15.6) 0.66 [0.25–1.95] 0.44 0.65 [0.22–1.91] 0.43 14 (8.8) 17 (16.0) 0.50 [0.22–1.14] 0.08 0.53 
[0.23–1.24] 
0.14 
Comorbidity (n = 286)             
No 209 (89.7) 47 (88.7)     147 (88.0) 109 (91.6)     
Yes 24 (10.3) 6 (11.3) 0.99 [0.35–2.49] 1.00 1.05 [0.40–2.78] 0.92 20 (12.0) 10 (8.4) 0.90 [0.42–1.91] 0.86 0.96 
[0.46–2.03] 
0.93  
* Odds ratios and p-values based on both Fisher tests of pairwise variable associations (“unadjusted”) and a multiple logistic regression involving all predictors (“adjusted”). 
** Although the effect of distance on fifth-visit attendance does not reach statistical significance in analysis of people with epilepsy alone, when all patients are analyzed the effect of distance is highly significant (p <
0.01). There is no interaction between epilepsy diagnosis and distance (p = 0.9 in a separate multiple logistic regression analysis not shown here), so it would be justified to base analysis of the effect of distance on the 
entire patient population. 
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services [1]. Children with epilepsy are at risk for behavioral distur-
bances [18] and reduced school attendance, as well as other conse-
quences such as burns, falls and drowning. Service provision for children 
with epilepsy should focus not only on optimal seizure control, but also 
family psychoeducation and addressing the significant morbidity and 
social stigma which is associated with epilepsy [17]. 
We found that males attending MESH MH supported services were 
more than twice as likely as women to carry a diagnosis of epilepsy. This 
may be because men have a higher burden of epileptic disorders in 
Rwanda, and our data agrees with epidemiologic studies demonstrating 
that men may be marginally more likely to have epilepsy [19]. For 
example, higher rates of epilepsy among males have been associated 
with risk factors such as increased rates of head injuries [20]. Trends 
toward gender differences may be also be seen in some common epilepsy 
syndromes, as well as other seizure sequelae [19]. Further character-
ization of the types of epilepsy seen at MESH MH supported services and 
their etiologies, and better understanding of the epidemiology of 
service-seekers versus the population prevalence of epilepsy, could 
better characterize both prevalence and gender differences among those 
with epilepsy in our catchment area. While most cases of epilepsy 
worldwide are idiopathic with no identifiable cause, questions remain as 
to potential specific characteristics and sources of epilepsy in Burera 
District (i.e., post-head injury, infectious—viral, bacterial, protozoal or 
parasitic, genetic or other), that may be reflective of its unique 
geographic, natural, historical or cultural context [2,21]. 
Our data reflected low levels of comorbid psychiatric diagnoses, 
particularly depression, among patients with epilepsy, with only 1% of 
patients in our study diagnosed with both epilepsy and a depressive 
disorder. Depression is estimated to be the most common comorbid 
psychiatric disorder with epilepsy, with estimated point prevalence 
ranging from 4% of seizure free patients in community settings, up to 
58% in those with medically intractable epilepsy [22]. People with ep-
ilepsy are at high risk for depression stemming from psychosocial factors 
such as stigma, but also neurological, with site and lateralization of 
seizure focus both possible contributors to the development of depres-
sion in patients with epilepsy [23]. Depression is undertreated across 
high income countries as well as resource limited settings, but may be 
more undertreated in epilepsy populations due to under-recognition of 
depressive symptoms, as well as potential concerns about drug in-
teractions and the risks of exacerbating seizures with antidepressant 
therapy. Our low recorded prevalence of depression in patients with 
epilepsy likely indicate that comorbid psychiatric diagnoses are being 
overlooked in patients with epilepsy served by the MESH MH program, 
and quality improvement measures to improve care for people with 
epilepsy should include basic screening and treatment protocols for 
depression and other psychiatric disorders. 
The most common medications prescribed for epilepsy treatment in 
our study were carbamazepine, valproate or phenobarbital mono-
therapy regimens, which together accounted for 84% of treatment reg-
imens administered by MESH MH supported services. These treatment 
regimens are aligned with World Health Organization treatment 
guidelines for standard antiepileptic treatment regimens, which include 
strong recommendations for these three medications in addition to 
phenytoin as initial treatment for convulsive epilepsy [24]. With basic 
treatment, seizure control can likely be achieved in up to 50% of patients 
and significant improvements in seizure frequency in up to 25% more, 
although the success rate depends on the type of seizure and extent of 
associated neurological abnormalities [25]. Further data on treatment 
adherence, seizure frequency, and functional status is needed to more 
accurately assess the efficacy of MESH MH services in improving the 
lives for people with epilepsy. 
In our study, people with epilepsy were significantly more likely to 
return to care than those with other diagnoses. This may be because 
families are more likely to return to care with their children, or because 
people perceive the treatment as being more effective than for other 
disorders. Distance to the health center may also play a role in return to 
care, as other IMB clinical programs in rural Rwanda have found that 
return to care is lower when patients have to travel farther for care [26]. 
Although the effect of distance on fifth-visit attendance did not reach 
statistical significance in analysis of people with epilepsy alone, when all 
patients were analyzed the effect of distance on fifth-visit attendance 
was highly significant (p < 0.01). It is possible that decentralization of 
health services to facilities nearer to patients’ homes via MESH MH has 
resulted in better follow up for all people with mental disorders, as well 
as those with epilepsy. Further research however is needed to explore 
the reasons for loss to follow up and to demonstrate whether the 
decentralization of mental health services to health centers via MESH 
MH has improved adherence to follow up care for people with epilepsy 
throughout the district. 
The primary limitation of this study is that it is a retrospective review 
of routinely collected with missing data and variation in data quality and 
completeness. Our study was also limited to data available in paper 
records at public health facilities throughout Burera district, and did not 
include specific data on clinical outcomes for people with epilepsy. 
However, despite the limitations, our study represents one of the first 
description of demographics, service utilization, and treatment patterns 
for patients with epilepsy receiving care from non-specialists in health 
centers in one rural district of Rwanda. Our results can be used to inform 
the gaps in epilepsy care that still exist in a rural Rwandan district and 
could be applied to other similar contexts. 
5. Conclusion 
There remains a great need to increase global awareness of the 
burden of epilepsy on individuals and their families, and its treatable 
nature. Implementation programs such as MESH MH, focused on accu-
rate diagnosis and treatment of epilepsy, including medication as well as 
psychosocial services, have the potential to reduce the occurrence of 
neurological sequelae and improve the quality of life for people living 
with epilepsy. Further research is needed to validate our findings and 
analyze patient level clinical outcomes and experiences of care, in order 
to inform programs and systems designed to bring decentralized, task- 
sharing in epilepsy care to scale. 
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